"Calcium disodium edetate (EDTA) holds historic regulatory approval since 1953 for acute lead poisoning and other specific uses."EDTA · FDA · since 1953
Toxins and detoxification. The science of eliminating what accumulates.
An editorial review of evidence on intravenous chelation with established agents (EDTA, DMPS, DMSA), high-performance IV glutathione, Therapeutic Plasma Exchange with Spectra Optia, and functional hepato-renal support applied to the supervised elimination of mercury, lead, aluminum, microplastics, and accumulated environmental toxic burden under individual medical criteria.
Who is it indicated for
Patients with symptoms compatible with toxic burden, documented exposure factors, or chronic complaints inexplicable by conventional medicine.
- Unexplained chronic fatigue
- Persistent brain fog and early cognitive decline
- Occupational exposure to metals or solvents
- Multiple or replaced dental amalgams
- Diet high in large fish (tuna, swordfish)
- Multiple chemical sensitivities
- Unexplained peripheral neuropathies
- Chronic elevated oxidative stress
Five medically supervised phases
Toxicity & Body Burden Analysis
Complete evaluation of heavy metal levels, environmental toxins, and endogenous detoxification capacity.
The diagnostic phase defines scope: provocation with chelator with pre and post urine analysis, capillary mineralogram per indication, oxidative stress biomarkers (8-OHdG, reduced/oxidized glutathione, F2-isoprostanes), hepatic phase I/II function evaluation, complete renal profile. Without documented diagnosis, no protocol is initiated.
Personalized IV Chelation
EDTA, DMPS, or DMSA selected based on individual toxic profile, administered under specialized medical supervision.
EDTA has FDA approval for lead poisoning and is chelator of choice for divalent metals. DMPS is the preferred agent for mercury and arsenic. DMSA offers both oral and IV administration with good profile for lead and mercury. Choice, dose, and sequence are adjusted to toxic profile, renal function, age, and comorbidities. Each session includes tolerance monitoring and mineral replacement.
High-Performance IV Glutathione
The master intracellular antioxidant administered intravenously to neutralize mobilized toxins and protect tissues during elimination.
Chelation mobilizes metals into circulation before renal elimination — a critical moment requiring robust antioxidant protection. IV glutathione avoids the limited bioavailability of oral route, provides direct support to hepatic phase II, and neutralizes oxidative stress generated by toxic mobilization. Administered as slow infusion interspersed with chelation sessions.
Therapeutic Plasma Exchange
Spectra Optia system for elimination of circulating toxins, toxic proteins, and inflammatory mediators that conventional chelation cannot reach.
Not all toxins are chelatable heavy metals. Modern environmental burden includes persistent organic pollutants, microplastics, and PFAS — substances for which conventional chelation has limited capacity. TPE acts on the complete plasmatic compartment and emerging literature suggests its role in reducing persistent chemical burden. See TPE science.
Functional Hepato-Renal Support
Restoration of elimination organ function with functional nutrition, hepatic antioxidants, and specific peptides.
Elimination organs must function optimally for detoxification to be safe. Support includes silymarin, N-acetylcysteine (NAC), alpha-lipoic acid, methylated B-complex, magnesium, and replacement of essential minerals also chelated (calcium, zinc, manganese). IV hydration pre and post-procedure is standard for renal protection.
Expected clinical outcomes
- Documented elimination of heavy metals
- Reduction of systemic body toxic burden
- Improvement in cognitive function and mental clarity
- Sustained increase in energy and vitality
- Modulation of chronic low-grade inflammation
- Improvement in oxidative stress biomarkers
- Documented mitochondrial function restoration
- Support of functional hepato-renal regeneration
Chelation isn't a wellness shot — it's precision medicine
- Complete baseline evaluation: extended renal function, electrolytes, hepatic, thyroid
- Provocation with chelator to quantify toxic burden before starting protocol
- Between-session monitoring of renal function, ionic calcium, magnesium, and clinical tolerance
- Systematic replacement of essential minerals chelated alongside toxic metals
- IV hydration pre and post-procedure for renal protection
- Post-protocol laboratory remeasurement to document effective elimination
- Chelators administered under medical criteria within the applicable regulatory framework
Key references
- FDA — EDTA Approval. Calcium disodium edetate has historic regulatory approval since 1953 for acute lead poisoning and other specific uses.
- Journal of Clinical Toxicology (2022). DMPS in occupational mercury exposure — Documented DMPS efficacy in urinary mercury elimination in occupational exposure.
- Environmental Health Perspectives (2024). PFAS removal in occupational cohorts — Emerging evidence on TPE role in reducing persistent chemical body burden.
- Nature Reviews Endocrinology (2023). Heavy metals and chronic disease — Systematic review on associations between accumulated toxic burden and cardiovascular, metabolic, and neurodegenerative disease.
Everything you need to know before deciding
What are heavy metals and how do they get into my body?
Heavy metals — mercury, lead, aluminum, arsenic, cadmium — accumulate in soft tissues, fat, and bone. Common sources: dental amalgams, large fish, occupational exposure, contaminated water, urban air pollutants, certain cosmetics or old kitchenware.
Is chelation therapy safe?
EDTA has FDA approval since 1953 for acute lead poisoning. DMPS and DMSA are established chelators. Safety critically depends on medical supervision, renal monitoring, mineral replacement, and appropriate chelator selection. Preventable risks include mineral depletion and renal overload.
How long does the protocol last?
Between 3 and 9 months depending on initial documented toxic burden, individual elimination capacity, and clinical objectives. Phases: evaluation, induction with weekly sessions, maintenance, and effective elimination monitoring.
Can I do detoxification at home with supplements?
Home protocols (chlorella, cilantro, zeolite) have limited clinical evidence for mobilizing and eliminating metals in clinically significant amounts. Risk of mobilizing metals without adequate elimination capacity — toxic redistribution — can worsen symptoms. Difference with medical protocol: documented capacity, monitoring, mineral management.
Regulatory framework
Chelation therapies and chelating agents are administered under individual medical evaluation, documented clinical indication, and within the applicable regulatory framework of INVIMA in Colombia.
The evidence that supports
medical detoxification
Three references that distinguish a medical detoxification protocol from wellness without traceability.
"DMPS documented efficacy in urinary mercury elimination in cohorts with chronic occupational exposure."DMPS · mercury · occupational exposure
"Emerging evidence on the role of Therapeutic Plasma Exchange in reducing the body burden of persistent synthetic chemicals (PFAS)."PFAS · TPE · body burden
What the body accumulates over decades doesn't eliminate itself. Medical detoxification is the clinical decision to give the body back the capacity to function without the toxic burden that silently erodes it.
Recovering cellular vitality, mental clarity, and metabolic resilience is possible when toxic burden is measured, mobilized, and eliminated under strict medical protocol. It's not magic — it's supervised biochemistry.
Begin with a toxic burden evaluation
In 60 minutes we review your exposure history, symptoms, and biomarkers. We define the appropriate diagnostic panel and design a personalized detoxification protocol under individual medical criteria.